Ireland· IE-PA-EU/1/00/162/014
Prandin
A repaglinide product containing repaglinide, registered in Ireland by Novo Nordisk A/S. The same ATC class is registered in 19 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Repaglinide is registered in 19 of 19 countries.
Countries holding a registration under ATC A10BX02 (repaglinide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 11 of them publish a price we can compare per daily dose
Repaglinide · ATC A10BX02
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of repaglinide costs, country by country.
Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.30 in France to $1.47 in Switzerland — a ×4.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Repaglinide · price per daily dose (4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.47
- IT Italy$0.39
- FR France$0.30
The record
At a glance
HPRA (Ireland)- Active substance
- Repaglinide
- Manufacturer
- Novo Nordisk A/S
- Country
- Ireland (IE)
- ATC code
- A10BX02
- ATC class
- Repaglinide
- Defined daily dose
- 4 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/00/162/014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
708 interactions on record for repaglinide.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Repaglinide · interactions on record
708 records
- 18 severe
- 502 moderate
- 41 minor
- 145 info
Most severe, free to view
- ClopidogrelB01AC04severe
- GemfibrozilC10AB04severe
- ClotrimazoleA01AB18moderate
- CimetidineA02BA01moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Repaglinide in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENYGLIDKrka, d.d., Novo mesto, Novo mesto
- United KingdomEnyglid 0.5mg tabletsKrka UK Ltd
- SpainEnyglid 0,5 mg comprimidos EFGKrka D.D. Novo Mesto
- ItalyNOVONORMNOVO NORDISK A/S
- FranceNOVONORM 0,5 mg, compriméNOVO NORDISK (DANEMARK)
- BelgiumEnyglid 0.5 mgKRKA d.d. Novo mesto
- FinlandEnyglidKRKA d.d. Novo mesto
- SwedenEnyglid 0,5 mg TablettKrka d.d., Novo mesto
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Repaglinid Ratiopharm, Repaglinid Sandoz
- Belgium · Repaglinide Eg
- Bulgaria · Индорин
- Cyprus · Theroflan
- Czechia · Vatinid
- Germany · Repaglinid 1 A Pharma, Repaglinid Abz
- Denmark · Repaglinid Doc Generici
- Spain · Repaglinida Alter, Repaglinida Aurovitas
- Finland · Repaglinid Stada
- France · Repaglinide Arrow Lab, Repaglinide Biogaran
- United Kingdom (Northern Ireland) · Repaglinide, Repaglinide Rivopharm Uk
- Greece · Theroflan
- Croatia · Reglinid, Repaglinid Pharmas
- Iceland · Enyglid, Novonorm
- Italy · Glicam, Repaglinide Aurobindo
- Liechtenstein · Repaglinide Teva
- Luxembourg · Repaglinide Eg
- Latvia · Repaglinide Elvim
- Malta · Repaglinide Aurobindo
- Netherlands · Repaglinide Stada
- Norway · Enyglid, Novonorm
- Romania · Reneos, Repaglinida Arena
- Sweden · Repaglinid Actavis, Repaglinid Stada
- Slovenia · Repaglinid Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3729bbe-3e7a-442c-ac07-3b20c83a686e GET /v1/drugs/c3729bbe-3e7a-442c-ac07-3b20c83a686e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A10BX",
"A10BX02"
],
"strength": null,
"pa_number": "EU/1/00/162/014",
"substances": [
"Repaglinide"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "29/01/2001",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about repaglinide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.